Pictet Asset Management Holding Sa Viking Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,921,436 shares of VKTX stock, worth $61.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,921,436
Previous 1,237,093
55.32%
Holding current value
$61.7 Million
Previous $49.8 Million
6.79%
% of portfolio
0.05%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding VKTX
# of Institutions
447Shares Held
65.4MCall Options Held
8.28MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$193 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$130 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$100 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$100 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.46B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...